{"product_id":"association-for-the-advancement-of-blood-biotherapies-annual-meeting-on-demand-2025","title":"Association for the Advancement of Blood \u0026 Biotherapies Annual Meeting On-Demand 2025","description":"\u003ch3\u003eAssociation for the Advancement of Blood \u0026amp; Biotherapies Annual Meeting On-Demand 2025\u003c\/h3\u003e\r\n+ Include: 112 videos + 112 audios + 112 file sub vtt + 112 pdfs, size: 90.42 GB\r\n\r\n+ Target Audience: hematologists, transfusion medicine specialists, and blood bank professionals\r\n\r\n+ Information:\r\n\u003ch3\u003e1. Overview\u003c\/h3\u003e\r\nThe Association for the Advancement of Blood \u0026amp; Biotherapies (AABB) Annual Meeting On-Demand 2025 provides a comprehensive review of the latest advancements in transfusion medicine and biotherapies. The course covers critical updates on blood banking, cellular therapies, patient blood management, and evolving regulatory standards to enhance clinical practices and patient safety.\r\n\r\nCourse Date: 2025\r\n\u003ch3\u003e2. Learning Objectives\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eEvaluate the latest advancements in transfusion medicine and patient blood management strategies.\u003c\/li\u003e\r\n \t\u003cli\u003eImplement updated protocols for blood banking, donor screening, and pathogen reduction.\u003c\/li\u003e\r\n \t\u003cli\u003eAnalyze emerging trends and clinical applications in cellular therapies and biotherapies.\u003c\/li\u003e\r\n \t\u003cli\u003eAssess regulatory changes and quality assurance standards impacting blood and biotherapy facilities.\u003c\/li\u003e\r\n \t\u003cli\u003eDevelop strategies to manage blood shortages and optimize inventory during public health emergencies.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e3. Target Audience\u003c\/h3\u003e\r\nBest for hematologists, transfusion medicine specialists, and blood bank professionals who want updates on biotherapies and blood management.\r\n\u003ch3\u003e4. Topics\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e2025 Ask the FDA and CMS_CLIA (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eA Tale of Twice-Annual Verification_ Why Two Matter, and Who’s Looking_ (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eAABB_ASHI Symposium_ Exploring Transplant Uncertainties_Conundrums in ABO (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eAABB_THOR Joint Session_ Some New Looks at Old Dogma, New Studies, and New Blood Products (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eAABB’s Updated Platelet and Red Blood Cell Transfusion Guidelines (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eAdvances in Labeling_ Practical Applications of 2-D Data Matrix Symbols with ISBT 128 (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eAdvancing Cord Blood Utilization_ Building Pathways for Innovation and Clinical Adoption (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eAllogeneic Transplant, Gene Therapy, or the Evolving Drug Landscape in Sickle Cell Disease_ Helping Patients Choose Between O..\u003c\/li\u003e\r\n \t\u003cli\u003eAlpha-Gal Syndrome_ Can Tick Bites Lead to Life-Threatening Allergic Transfusion Reactions_ (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eAM25-MN-07-O_ Cell Therapy Lab Jeopardy! (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eAsk the Standards (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eAssessor Townhall Assessment Readiness-Get Ready and Stay Ready\u003c\/li\u003e\r\n \t\u003cli\u003eBasic Blood Biology and Mechanisms of Immunity in Transfusion Medicine and Biotherapies (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eBlood Bank IT_ Compliance and Data Management Concepts (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eBlood Conservation in the OR_ How to Create a Comprehensive Pediatric Patient Blood Management Program (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eBlood Products as Pharmaceuticals_ Should that be our Goalÿ(Tibor Greenwalt Memorial Award and Lectureship) (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eBPDR Demystified_ A Practical Guide to Reporting and Preventing Errors (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eBuilding a Translational Arm to Your Cellular Therapy Laboratory (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eBuilding Trust-Based Teams_ A Strategic Imperative for Leaders (Enduring)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003eCABP Exam Prep (Enduring)\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eCBC_ A New Era for Cord Blood – The National Cord Blood Network (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eCBC_ Defining Novel Growth Opportunities for the Cord Blood Field_ Lessons Learned \u0026amp; Pathways Forward (Enduring) [CABP CE ELI..\u003c\/li\u003e\r\n \t\u003cli\u003eCBC_ Emerging Issues in Cord Blood Therapeutics and Gene Therapies (President’s Session) (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eCBC_ Evidence Based Communication in Cord Blood Donation and Banking (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eCBC_ Exploring the Unique Biology of Cord Blood and Birthing Tissues (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eCBC_ How does Cord Blood Facilitate Tissue Repair and Regeneration_ (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eCBC_ Innovative Approaches in Cord Blood Transplantation_ Clinical Outcomes and New Strategies (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eCBC_ Lightning Talks – The Future of Cord Blood_ Bold Visions \u0026amp; Innovations (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eCBC_ Opportunities \u0026amp; Challenges the Field of Cord Blood and Birthing Tissues (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eCBC_ State of the Science Symposium – Striking a New Cord in the Evolution of Stem Cell Transplant (Enduring) [CABP CE ELIGIB..\u003c\/li\u003e\r\n \t\u003cli\u003eCBC_ The New Frontiers of MSC’s in Regenerative Medicine (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eChoose Your Own Adventure_ Spooky Serology, Mysterious Molecular, and Eerie Incompatibility (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eClosing the Divide_ Pathways to Engaging Underrepresented Communities in Blood Donation (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eCold Truths_ The Potential Hidden Impact of “Clinically Insignificant” Antibodies in Hypothermic Cardiac Surgery (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eComputer Systems Under Attack_ Cybersecurity Best Practices and Lessons Learned (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eCOVID-19 Convalescent Plasma in the Immunocompromised Patient (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eCreating Effective Donor Recruitment Videos Through the Use of Co-Design with Community Partners (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eCrossmatch Incompatible Transfusions_ How Collaboration Between Transfusion Services and Immunohematology Reference Laborator..\u003c\/li\u003e\r\n \t\u003cli\u003eDonating for the Future_ Bridging Generations and Communities for a Stronger Blood Supply (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eEnhancing Perioperative Autologous Transfusion_ Bridging the Gap Between Standards and Practice (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eEnsuring Ethical and Regulatory Compliance in Donor Collections for Advanced Therapies (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eEnsuring Safe and Effective Distribution of Advanced Therapies_ Unique Perspectives from Pharmacy and Cell Therapy Labs (Endu..\u003c\/li\u003e\r\n \t\u003cli\u003eEthical Dilemmas in Compensating Blood Donors_ Navigating Global Health Perspectives (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eEvolving Immunologic Concepts – From Basic Mechanisms to Translation (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eExpanding Access, Ensuring Safety_ Best Practices in Out-of-Hospital Transfusion (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eExpanding CGT Access_ The Role of Blood Centers in Last-Mile Delivery (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eFcRN Inhibitors – a New Era for Transfusion Medicine_ (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eFrom Blueprint to Benchmark_ A Journey Through AABB Standards Development and Accreditation (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eFrom Fellow to Faculty_ Practical Insights for Trainees and Early Career Physicians (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eGenerations Apart and Together_ Navigating Today’s Culture to Build a Sustainable Workforce for Your Transfusion Service (End..\u003c\/li\u003e\r\n \t\u003cli\u003eHow New Red Cell Antigens Are Identified, Classified, Added to a Blood Group System or Creating a New Blood Group System, The..\u003c\/li\u003e\r\n \t\u003cli\u003eI Want It That Way Ethical Dilemmas in Pediatric Transfusion Medicine (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eImplementation of Lab Automation_ Best Practices and Benefits (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eImproving Recognition and Reporting of Transfusion Reactions_ Data-Driven Insights and Quality Improvement Strategies (Enduri..\u003c\/li\u003e\r\n \t\u003cli\u003eInclusive Blood Donation Strategies for 2SLGBTQIA+ Communities_ Rebuilding Trust and “Adding Your Sparkle to the Blood Supply..\u003c\/li\u003e\r\n \t\u003cli\u003eInteractive Panel and Audience Discussion_ Navigating Clinical, Professional, and Ethical `Sticky Wickets’ in Leukapheresis f..\u003c\/li\u003e\r\n \t\u003cli\u003eIRL Accreditation_ Case Studies and Helpful Hints for Better Conformance (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eIron Matters_ Regulating the Metal That Makes Blood Red (Landsteiner-Alter Award and Lectureship) (Enduring)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003eLord of the Antibodies (Enduring)\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eMaximum Surgical Blood Order Schedule (MSBOS)_ Return on Investment, Implementation, and AI (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eNovel Insights into Iron Toxicities in Hematologic Diseases and Related Pharmacological and GeneÿTherapy Approaches (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eNovel Tools and Platform Designs in Biotherapies (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eOptimization of Postpartum Hemorrhage Management in the Academic and Community Setting (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – Advances in Cord Blood Therapy (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – Application of Novel Technology in Transfusion Medicine (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – Hematology \u0026amp; Coagulation (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – Infectious Diseases \u0026amp; Transfusion Medicine (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – Insight into Whole Blood and Hemorrhage Management (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – Lessons From the Immunohematology Lab (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – New Insights into Components, Storage, and Patient Outcomes (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – New Insights to Patient Blood Management (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – New Variants in Kid \u0026amp; ABO (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – Non-Infectious Hazards of Blood Transfusion (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – Novel RHCE Variants (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – Novel RHD Variants and Approaches to Overcoming Them (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – Pediatric Transfusion Practice (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Session – Therapeutic and Donor Apheresis and Blood Donation Infectious Disease (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Spotlight Session – Biotherapies \u0026amp; Cell Transplantation (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Spotlight Session – Cutting Edge Insights into Blood Donations and Allocations (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eOral Abstract Spotlight Session – Discoveries in the Science of Immunohematology (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003ePlanning for Disease X_ To Ensure a Safe and Sufficient Blood Supply During the Next Emerging Pathogen Event (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003ePlasma Failure in Multiple Organ Dysfunction Syndrome (MODS) (Enduring)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003ePlenary Abstract (Enduring)\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003ePrehospital Transfusion Workshop_ Building Effective EMS Programs (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eQuality Agreements in Cell Therapy_ Building Successful Partnerships (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eReducing O Negative RBC Overutilization in Pediatric Transfusion Medicine_ Overcoming Challenges (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eResearch and Progress (RAPS)_ Organoids in Research and Biotherapies_ Promise, Progress, and Challenges (Enduring) [CABP CE E..\u003c\/li\u003e\r\n \t\u003cli\u003eResearch and Progress (RAPS)_ Whole Blood in Modern Transfusion Practice – A Debate on Evidence and Application (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eRevolutionizing Donor Selection_ Integrating AI, Omics Data, and Large-Scale Cohorts for Improved Cell Therapy Outcomes (Endu..\u003c\/li\u003e\r\n \t\u003cli\u003eSafety, Standards, and Sanity_ Navigating Compliance in Emergent Blood Product Release (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eSaving Infant Lives Through Public-Private Partnership_ The Development of an FDA-Approved Therapy for Infant Botulism (Endur..\u003c\/li\u003e\r\n \t\u003cli\u003eShould We Bring ABO Genotyping to Our Institution_ Things to Know About Taking the Leap (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eTest Your Blood Bank Knowledge 2025 – Are You up for a Challenge_ (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eThe Monocyte Monolayer Assay in Transfusion Medicine_ Historical Insights and Clinical Applications (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eThe Peer-Review Publication Process – How to Dip Your Toe in the Author and Reviewer Waters (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eThe Specialization of Hospital Transfusion Committees_ Pragmatic Approaches to Increasing Interest and Effectiveness (Endurin..\u003c\/li\u003e\r\n \t\u003cli\u003eThe Top Nonconformances Stratified by Facility Size and Location. Where Do You Fit_ (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eThe Transformative Power of Artificial Intelligence and Machine Learning_ From Blood Collectors to the Transfusion Service, a..\u003c\/li\u003e\r\n \t\u003cli\u003eThink Like a Detective_ Investigating Quality Issues with Root Cause Analysis (RCA) Tools (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eTransfusing Safely and Wisely_ Much Progress ButÿStill Need to Do Better (Emily Cooley Memorial Award and Lectureship) (Endur..\u003c\/li\u003e\r\n \t\u003cli\u003eTransfusion Medicine and Blood Bank Practice Guidelines for Von Willebrand Disease in Pregnancy (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eTransfusion Medicine Education for Physicians_ Ready-to-Use, Customizable, and Innovative Teaching Tools (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eTransfusion Medicine, Hemostasis, Apheresis, and Cellular Therapy Review Session for Trainees (Enduring) [CABP CE ELIGIBLE]\u003c\/li\u003e\r\n \t\u003cli\u003eUncovering New Blood Groups_ Impacts in Transfusion and Beyond (Sally Frank Award and Lectureship) (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eUnderstanding Generative AI_ A Friendly Introduction for Medical Professionals (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eUnexplained Reactivity in Red Cell Antibody Identification_ A Way Through (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eUnlocking the Power of Extracellular Vesicles_ From Intercellular Communication to Therapeutic Innovation (Enduring) [CABP CE..\u003c\/li\u003e\r\n \t\u003cli\u003eUpdate on the Use of Cryopreserved Platelets in Acute Surgical Settings (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eVeterinary Transfusion Medicine_ An Overview of Blood Banking for Our Furry Friends (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eWhat’s New in Transfusion Therapy for Sickle Cell Disease (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eWhen the Refrigerator Is Bare – Innovations from the Blood DESERT Coalition (Enduring)\u003c\/li\u003e\r\n \t\u003cli\u003eWhy, When and How Should You Use Electronic Batch Records (EBRs) in the Cell and Gene Therapy Manufacturing Process (Enduring..\u003c\/li\u003e\r\n\u003c\/ul\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954562240610,"sku":"MED-AMB06132","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Association-for-the-Advancement-of-Blood-Biotherapies-Annual-Meeting-On-Demand-2025_bc41df17-305f-457a-9a4f-1906db733168.jpg?v=1779379755","url":"https:\/\/meducourse.com\/products\/association-for-the-advancement-of-blood-biotherapies-annual-meeting-on-demand-2025","provider":"Meducourse","version":"1.0","type":"link"}